Medtronic, Inc. And Covidien plc Unveil Their Integration Teams

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

This week merging device makers Covidien (NYSE:COV) and Medtronic (NYSE:MDT) jointly named more than 45 people to take an intimate interest in the companies' high-profile integration.

The appointees (full list below) include employees from both sides who have been tasked with coordinating the finer points of the $43 billion mega-merger. The teams will tackle all specific functions and business areas under the supervision of the Joint Steering Committee, which is comprised of senior leaders from both Medtronic and Covidien.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news